Since 1989, 17 patients have undergone re-irradiation for locally recu
rrent nasopharyngeal cancer (NPC). The dose currently administered ext
ernally is 39.6 Gy in 36 fractions (BID) followed by an intracavitary
boost (15-20 Gy). Disease persisted in five out of five patients treat
ed palliatively, Eleven of 12 patients treated with curative intent ac
hieved local control. (C) 1998 Elsevier Science Ireland Ltd. All right
s reserved.